香港股市 已收市

ZY Jan 2023 2.500 call

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
0.95000.0000 (0.00%)
收市價: 02:52PM EST
全螢幕
前收市價0.9500
開市1.0000
買盤0.0000
賣出價0.0000
拍板2.50
到期日2023-01-20
今日波幅0.9500 - 1.0000
合同範圍
成交量25
未平倉合約951
  • Benzinga

    Ginkgo Bioworks Expands Horizontal Synthetic Biology Platform With This Stock Deal

    Ginkgo Bioworks Holdings Inc (NYSE: DNA) agreed to acquire Zymergen Inc (NASDAQ: ZY) in an all-stock transaction. Zymergen stockholders will receive 0.9179 shares of Ginkgo's Class A common stock for each Zymergen share. The deal values Zymergen at approximately $300 million and would provide Zymergen shareholders about 5.25% pro forma ownership of Ginkgo. Ginkgo plans to integrate Zymergen's core automation and software technologies for scaling strain engineering capacity into its foundry, incl

  • Benzinga

    Zymergen Highlights Early Results From Work On Potential COVID-19 Drug Candidate

    Zymergen Inc (NASDAQ: ZY) announced early results from its work on infectious disease, discovering several potential novel hits against malaria, tuberculosis, and COVID-19 targets. Hits for PfAPP, a critical target in the treatment of malaria, are now being advanced for validation, with hits for an emerging COVID-19 target, PLpro, expected to follow. The multi-target infectious disease program is supported by a Bill & Melinda Gates Foundation grant, enabling Zymergen to identify novel hits for a